HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jyh-Ping Chen Selected Research

graphene oxide

6/2022Targeted delivery of irinotecan and SLP2 shRNA with GRP-conjugated magnetic graphene oxide for glioblastoma treatment.
9/2021Magnetic and GRPR-targeted reduced graphene oxide/doxorubicin nanocomposite for dual-targeted chemo-photothermal cancer therapy.
3/2021Functionalized Reduced Graphene Oxide as a Versatile Tool for Cancer Therapy.
9/2020Injectable Thermo-Sensitive Chitosan Hydrogel Containing CPT-11-Loaded EGFR-Targeted Graphene Oxide and SLP2 shRNA for Localized Drug/Gene Delivery in Glioblastoma Therapy.
1/2020Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells.
3/2018Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy.
12/2017Soft Electrochemical Probes for Mapping the Distribution of Biomarkers and Injected Nanomaterials in Animal and Human Tissues.
11/2017Intratumoral Delivery of Doxorubicin on Folate-Conjugated Graphene Oxide by In-Situ Forming Thermo-Sensitive Hydrogel for Breast Cancer Therapy.
1/2012Improving thermal stability and efficacy of BCNU in treating glioma cells using PAA-functionalized graphene oxide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jyh-Ping Chen Research Topics

Disease

17Neoplasms (Cancer)
06/2022 - 01/2012
5Glioblastoma (Glioblastoma Multiforme)
06/2022 - 01/2012
5Glioma (Gliomas)
06/2022 - 10/2010
4Brain Neoplasms (Brain Tumor)
06/2022 - 10/2010
3Wounds and Injuries (Trauma)
01/2021 - 11/2010
3Thrombosis (Thrombus)
04/2020 - 01/2012
3Cleft Lip (Harelip)
01/2018 - 04/2016
2Tissue Adhesions
05/2022 - 10/2017
2Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 09/2020
2Cicatrix (Scar)
01/2021 - 01/2018
2Hyperthermia
07/2020 - 01/2019
2Inflammation (Inflammations)
10/2019 - 01/2018
2Hypertrophy
01/2019 - 01/2018
1Dentofacial Deformities
11/2021
1Congenital Abnormalities (Deformity)
01/2021
1Neuroblastoma
10/2020
1Hemorrhage
04/2020
1Hemolysis
04/2020
1Ischemic Stroke
04/2020
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Nasopharyngeal Carcinoma
01/2020
1Stroke (Strokes)
09/2019
1Thromboembolism
09/2019
1Peritoneal Neoplasms
05/2018
1Infections
01/2018
1Hypertrophic Cicatrix (Hypertrophic Scar)
01/2018
1Melanoma (Melanoma, Malignant)
12/2017
1Breast Neoplasms (Breast Cancer)
11/2017

Drug/Important Bio-Agent (IBA)

17Pharmaceutical PreparationsIBA
06/2022 - 10/2010
9graphene oxideIBA
06/2022 - 01/2012
5Doxorubicin (Adriamycin)FDA LinkGeneric
09/2021 - 01/2012
4LigandsIBA
06/2022 - 01/2012
4Hyaluronic Acid (Hyaluronan)IBA
05/2022 - 10/2015
4HydrogelsIBA
05/2022 - 10/2017
3Small Interfering RNA (siRNA)IBA
06/2022 - 09/2020
2Irinotecan (Camptosar)FDA LinkGeneric
06/2022 - 09/2020
2poly(lactide) (polylactic acid)IBA
01/2022 - 09/2020
2Docosahexaenoic AcidsIBA
01/2022 - 09/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2021 - 06/2021
2Photosensitizing Agents (Photosensitizers)IBA
06/2021 - 03/2021
2CollagenIBA
01/2021 - 11/2010
2Saline SolutionIBA
01/2021 - 03/2018
2Proteins (Proteins, Gene)FDA Link
10/2020 - 12/2017
2Liposomes (Liposome)IBA
07/2020 - 01/2019
2Biological ProductsIBA
04/2020 - 01/2019
2Ibuprofen (Motrin)FDA LinkGeneric
10/2019 - 01/2018
2Carbon Nanotubes (Carbon Nanotube)IBA
12/2017 - 01/2012
2Folic Acid (Vitamin M)FDA LinkGeneric
11/2017 - 01/2012
2SilverIBA
10/2015 - 11/2010
2Carmustine (FIVB)FDA Link
01/2012 - 10/2010
1Gastrin-Releasing PeptideIBA
06/2022
1Carboxymethylcellulose Sodium (Polycell)FDA Link
05/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021
12- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA
07/2021
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
07/2021
1Singlet OxygenIBA
06/2021
1Coloring Agents (Dyes)IBA
06/2021
1CarbonIBA
03/2021
1GraphiteIBA
03/2021
1Type A Botulinum Toxins (Botox)FDA Link
01/2021
1SteamIBA
01/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1Botulinum Toxins (Botulinum Toxin)IBA
01/2021
1CurcuminIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
09/2020
1Cetuximab (Erbitux)FDA Link
09/2020
1ChitosanIBA
09/2020
1ferric oxide (iron oxide)IBA
07/2020
1Citric Acid (Citrate)FDA LinkGeneric
07/2020
1SuspensionsIBA
07/2020
1Tissue Plasminogen Activator (Alteplase)FDA Link
04/2020
1Fibrinolytic Agents (Antithrombotic Agents)IBA
04/2020
1FibrinIBA
04/2020
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2020
1Plasminogen Activators (Plasminogen Activator)IBA
09/2019
1incobotulinumtoxinAFDA Link
01/2019
1SiliconesIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
12/2017
1LuciferasesIBA
11/2017

Therapy/Procedure

11Therapeutics
06/2022 - 01/2012
6Lasers (Laser)
09/2021 - 11/2017
4Drug Therapy (Chemotherapy)
06/2021 - 01/2019
4Injections
01/2021 - 10/2017
3Photothermal Therapy
09/2021 - 03/2021
3Photochemotherapy (Photodynamic Therapy)
07/2021 - 01/2019
3Phototherapy (Light Therapy)
06/2021 - 03/2018
2Orthognathic Surgery
11/2021 - 01/2017
2Immunotherapy
06/2021 - 03/2021
2Precision Medicine
06/2021 - 12/2017
2Radiotherapy
03/2021 - 01/2020
2Alveolar Bone Grafting
12/2017 - 04/2016
1Intravenous Administration
06/2022
1Rhinoplasty
01/2021
1Blepharoplasty
01/2021
1Intravenous Infusions
04/2020
1Thrombolytic Therapy
09/2019
1Postoperative Care
01/2018